Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic’s Department of Radiation ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

What used to be a niche treatment for men with legitimate medical conditions has morphed into "youth and vigor" as a ...

Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients with undetectable PSA levels.

Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large ...

To examine the role of PHI in detecting clinically significant cancer among biopsy-naïve men with a PSA between 10-20 ng/mL. We studied biopsy-naïve men who underwent PHI testing followed by prostate ...

Drew Swanson is a Features Article Editor from the Pacific Northwest of the United States. He is a lifelong gamer with a passion for a variety of genres. A connoisseur of everything from JRPGs and ...

PSA parent company Collectors reached an agreement to acquire grading competitor Beckett, the company announced Monday. Beckett will remain an independent brand and continue to utilize its own ...

Prostate cancer diagnoses are rising even as treatments improve — and researchers still don’t know why. Uncovering the cause could transform prevention and care for millions. The American Cancer ...